MedKoo Cat#: 564360 | Name: V4-015

Description:

WARNING: This product is for research use only, not for human or veterinary use.

V4-015 is a potent inhibitor of FGFR4 kinase activity.

Chemical Structure

V4-015
V4-015
CAS#NONE

Theoretical Analysis

MedKoo Cat#: 564360

Name: V4-015

CAS#: NONE

Chemical Formula: C26H30ClN9OS

Exact Mass: 551.1983

Molecular Weight: 552.10

Elemental Analysis: C, 56.56; H, 5.48; Cl, 6.42; N, 22.83; O, 2.90; S, 5.81

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
V4015; V4 015; V4-015
IUPAC/Chemical Name
2-(4-(6-Chloro-2-(4-(4-methylpiperazin-1-yl)phenyl)-3H-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)-N-(thiazol-2-yl)acetamide
InChi Key
OHQOURUADKYVHS-UHFFFAOYSA-N
InChi Code
InChI=1S/C26H30ClN9OS/c1-33-7-11-35(12-8-33)19-4-2-18(3-5-19)24-31-22-23(20(27)16-29-25(22)32-24)36-13-9-34(10-14-36)17-21(37)30-26-28-6-15-38-26/h2-6,15-16H,7-14,17H2,1H3,(H,28,30,37)(H,29,31,32)
SMILES Code
O=C(NC1=NC=CS1)CN2CCN(C3=C4C(NC(C5=CC=C(N6CCN(C)CC6)C=C5)=N4)=NC=C3Cl)CC2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 552.10 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Ho HK, Németh G, Ng YR, Pang E, Szántai-Kis C, Zsákai L, Breza N, Greff Z, Horváth Z, Pató J, Szabadkai I, Szokol B, Baska F, Őrfî L, Ullrich A, Kéri G, Chua BT. Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing. Curr Med Chem. 2013;20(10):1203-17. PubMed PMID: 23409720.